Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland

被引:4
|
作者
Cypryk, Katarzyna [1 ]
Wender-Ozegowska, Ewa [2 ]
Cyganek, Katarzyna [3 ,4 ]
Sieradzki, Jacek [4 ]
Skoczylas, Kinga [5 ]
Chen, Xiaoxiao [6 ]
Cordero, Toni L. L. [6 ]
Shin, John [6 ]
Cohen, Ohad [7 ]
机构
[1] Med Univ Lodz, Dept Internal Dis & Diabetol, Pomorska Str 251, PL-92213 Lodz, Poland
[2] Poznan Univ Med Sci, Dept Reprod, Poznan, Poland
[3] Univ Hosp Krakow, Dept Metab Dis, Krakow, Poland
[4] Jagiellonian Univ Krakow, Coll Med, Krakow, Poland
[5] Medtronic, Warsaw, Poland
[6] Medtronic, Northridge, CA USA
[7] Medtronic, Tolochenaz, Switzerland
关键词
Type 1 diabetes-complicated pregnancy; HbA1c; Continuous subcutaneous insulin infusion (CSII); Continuous glucose monitoring (CGM); Large for gestational age (LGA); Neonatal outcomes; GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; OUTCOMES; INFUSION; RISK; MELLITUS; IMPLEMENTATION; KETOACIDOSIS; PREECLAMPSIA; ASSOCIATION;
D O I
10.1007/s00592-022-02020-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsThe effects of continuous subcutaneous insulin infusion (CSII) therapy with or without continuous glucose monitoring (CGM) on neonatal outcomes and glycemic outcomes of pregnant women with type 1 diabetes (T1D), living in Poland, were assessed.MethodsThis prospective observational study enrolled women with T1D (N = 481, aged 18-45 years) who were pregnant or planned pregnancy. All used CSII therapy and a subset used CGM with CSII (CSII + CGM). Neonatal outcomes (e.g., rate of large for gestational age [LGA] delivery [birth weight > 90th percentile]) and maternal glycemia (e.g., HbA1c and percentage of time at sensor glucose ranges) were evaluated.ResultsOverall HbA1c at trimesters 1, 2, and 3 was 6.8 +/- 1.1% (50.9 +/- 12.3 mmol/mol, N = 354), 5.8 +/- 0.7% (40.1 +/- 8.0 mmol/mol, N = 318), and 5.9 +/- 0.7% (41.4 +/- 8.0 mmol/mol, N = 255), respectively. A HbA1c target of < 6.0% (42 mmol/mol) at each trimester was achieved by 20.9% (74/354), 65.1% (207/318), and 58.0% (148/255), respectively. For women using CSII + CGM versus CSII only, HbA1c levels at trimesters 1, 2, and 3 were 6.5 +/- 0.9% versus 7.1 +/- 1.3% (47.8 +/- 9.7 mmol/mol versus 54.3 +/- 14.0 mmol/mol, p < 0.0001), 5.7 +/- 0.6% versus 6.0 +/- 0.9% (38.9 +/- 6.5 mmol/mol versus 41.6 +/- 9.3 mmol/mol, p = 0.0122), and 5.8 +/- 0.6% versus 6.1 +/- 0.8% (40.3 +/- 6.9 mmol/mol versus 42.9 +/- 9.1 mmol/mol, p = 0.0117), respectively. For the overall, CSII only, and CSII + CGM groups, rates of LGA delivery were 22.7% (74/326), 24.6% (34/138), and 21.3% (40/188), respectively.ConclusionsObservational assessment of women with T1D using CSII therapy demonstrated low HbA1c throughout pregnancy and low rates of LGA. The addition of CGM to CSII therapy compared to CSII therapy alone was associated with some improved maternal glycemic and neonatal outcomes.Clinicaltrials.gov identifierNCT01779141 (January 2013).
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [1] Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland
    Katarzyna Cypryk
    Ewa Wender-Ozegowska
    Katarzyna Cyganek
    Jacek Sieradzki
    Kinga Skoczylas
    Xiaoxiao Chen
    Toni L. Cordero
    John Shin
    Ohad Cohen
    Acta Diabetologica, 2023, 60 : 553 - 561
  • [2] Objectives and methods of the ORCHESTRA FOUNDATION Registry study: a multicenter observational study of the use of insulin pump therapy in pregnant women with type 1 diabetes mellitus in Poland
    Sieradzki, Jacek
    Cyganek, Katarzyna
    Cypryk, Katarzyna
    Wender-Ozegowska, Ewa
    Skoczylas, Kinga
    Runzis, Sarah
    Shin, John
    CLINICAL DIABETOLOGY, 2018, 7 (03): : 136 - 144
  • [3] Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus
    Lason, Izabela
    Cyganek, Katarzyna
    Witek, Przemyslaw
    Matejko, Bartlomiej
    Malecki, Maciej T.
    Skupien, Jan
    GINEKOLOGIA POLSKA, 2021, 92 (10) : 675 - 681
  • [4] Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies
    Karl Kristensen
    Linda E. Ögge
    Verena Sengpiel
    Karin Kjölhede
    Annika Dotevall
    Anders Elfvin
    Filip K. Knop
    Nana Wiberg
    Anastasia Katsarou
    Nael Shaat
    Lars Kristensen
    Kerstin Berntorp
    Diabetologia, 2019, 62 : 1143 - 1153
  • [5] Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies
    Kristensen, Karl
    Ogge, Linda E.
    Sengpiel, Verena
    Kjolhede, Karin
    Dotevall, Annika
    Elfvin, Anders
    Knop, Filip K.
    Wiberg, Nana
    Katsarou, Anastasia
    Shaat, Nael
    Kristensen, Lars
    Berntorp, Kerstin
    DIABETOLOGIA, 2019, 62 (07) : 1143 - 1153
  • [6] Insulin pump therapy in pregnant women with type 1 diabetes: intermittently scanned glucose monitoring vs sensor augmented pump
    Sola, C.
    Mariaca Riveros, K.
    Milad, C.
    Roca, D.
    Amor, A.
    Gimenez, M.
    Bellart, J.
    Vinagre, I.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S244 - S245
  • [7] Continuous glucose monitoring in pregnant women with type 1 diabetes
    Garg, Satish K.
    Polsky, Sarit
    LANCET, 2017, 390 (10110): : 2329 - 2331
  • [8] Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study
    Polsky, Sarit
    Garcetti, Rachel
    Pyle, Laura
    Joshee, Prakriti
    Demmitt, Jamie K.
    Snell-Bergeon, Janet K.
    PLOS ONE, 2020, 15 (04):
  • [9] Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy
    Heptulla, RA
    Allen, HF
    Gross, TM
    Reiter, EO
    PEDIATRIC DIABETES, 2004, 5 (01) : 10 - 15
  • [10] Continuous glucose monitoring and insulin pump therapy for diabetes in pregnancy
    Combs, C. Andrew
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (10): : 2025 - 2027